Publications by authors named "Rachele Lipsky"

Article Synopsis
  • * Out of 876 providers, only 10% were aware of their patients' PGx test status, with 64% not having ordered any PGx tests in the past year.
  • * Most providers (55%) believed PGx testing could be valuable for pain medication prescriptions, and 51% indicated a need for local experts to assist with PGx testing, highlighting areas for improvement in the Veterans Health Administration's approach to pain management.
View Article and Find Full Text PDF
Article Synopsis
  • - The PACT Act of 2022 has spurred interest in studying toxic exposures among military personnel, with a focus on developing epigenomic biomarkers that could reveal health effects linked to these exposures.
  • - A study involving 22 Veterans highlighted that many are interested in receiving information about their toxic exposure and its health implications, citing benefits like understanding intergenerational health and early interventions.
  • - Despite the positive attitudes towards epigenomic research, Veterans expressed concerns about potential risks, including psychological distress and issues of privacy, indicating a complex sentiment towards this type of testing.
View Article and Find Full Text PDF

Background: With the signing of the PACT Act in 2022, there is great interest and investment in studying toxic exposures encountered during military service. One way to address this is through the identification of epigenomic biomarkers associated with exposures. There is increasing evidence suggesting that exposure to toxic substances may result in alterations to DNA methylation and resultant gene expression.

View Article and Find Full Text PDF

Intimate partner violence (IPV) and HIV are serious and related public health problems that detrimentally impact women's health. Because women who experience IPV are more likely to acquire HIV, it is critical to promote HIV prevention strategies, such as HIV pre-exposure prophylaxis (PrEP), that increase autonomy. This study of cisgender women eligible for HIV PrEP took place between 2017 and 2019 in Philadelphia and New York City.

View Article and Find Full Text PDF
Article Synopsis
  • - Women who use drugs (WWUD) are at a high risk for HIV and could benefit from pre-exposure prophylaxis (PrEP), yet their uptake of PrEP is low due to various factors.
  • - A study involving 233 HIV-negative women in NYC and Philadelphia revealed that many engaged in drug use, with significant percentages perceiving themselves at risk for HIV and expressing intentions to start PrEP after becoming informed about it.
  • - The research indicates that while prescription opioid and polydrug users saw themselves at greater risk and were more willing to initiate PrEP, they had lower awareness of PrEP compared to other eligible women, highlighting the need for better education on the topic.
View Article and Find Full Text PDF

HIV pre-exposure prophylaxis (PrEP) uptake among cisgender women in the United States is low. Just4Us, a theory-based counseling and navigation intervention, was evaluated in a pilot randomized controlled trial among PrEP-eligible women (n = 83). The comparison arm was a brief information session.

View Article and Find Full Text PDF

Traumatic experiences and genetic heritability are among the most widely acknowledged risk factors leading to the development of psychopathology; including posttraumatic stress disorder (PTSD) and major depressive disorder (MDD). The purpose of this study was to investigate if polygenic risk scores (PRS) among Veterans interacted with traumatic stress to predict PTSD and MDD. 1,389 Iraq-Afghanistan military service Veterans from the Mental Illness Research Education and Clinical Center dataset were analyzed.

View Article and Find Full Text PDF

Background: Recent studies have examined the role that the serotonergic system plays in moderating the association between adverse childhood experiences (ACEs) and depressive and anxiety disorders in adulthood. The aim of this literature review is to synthesize studies that examined serotonin's impact in relation to ACEs, and depressive and anxiety disorders in this population.

Methods: Published studies from 2008 to 2018 were retrieved from PubMed, CINAHL, and PsychINFO databases, and were included if ACEs, the serotonergic system, and depressive and or anxiety disorders were assessed in those with a mean age between nineteen and forty.

View Article and Find Full Text PDF

In the United States, pre-exposure prophylaxis (PrEP) uptake among eligible cisgender women has been slow, despite the availability of oral PrEP since 2012. Although women make up nearly 20% of those living with HIV, there are currently few PrEP uptake interventions for cisgender women at elevated risk for acquiring HIV. Here we describe the process used to design and pre-pilot test Just4Us, a theory-based behavioral intervention to promote PrEP initiation and adherence among PrEP-eligible cisgender women.

View Article and Find Full Text PDF

The glucagon-like peptide-1 receptor (GLP-1R) agonist liraglutide is approved for the treatment of obesity; however, there is still much to be learned regarding the neuronal sites of action that underlie its suppressive effects on food intake and body weight. Peripherally administered liraglutide in rats acts in part through central GLP-1Rs in both the hypothalamus and the hindbrain. Here, we extend findings supporting a role for hindbrain GLP-1Rs in mediating the anorectic effects of liraglutide in male rats.

View Article and Find Full Text PDF

A growing appreciation of the overlapping neuroendocrine mechanisms controlling energy balance has highlighted combination therapies as a promising strategy to enhance sustained weight loss. Here, we investigated whether amylin- and glucagon-like-peptide-1 (GLP-1)-based combination therapies produce greater food intake- and body weight-suppressive effects compared to monotherapies in both lean and diet-induced obese (DIO) rats. In chow-maintained rats, systemic amylin and GLP-1 combine to reduce meal size.

View Article and Find Full Text PDF

Voltage-dependent calcium channels (VDCCs) play a pivotal role in normal excitation-contraction coupling in cardiac myocytes. These channels can be modulated through activation of beta-adrenergic receptors (beta-ARs), which leads to an increase in calcium current (I(Ca-L)) density through cardiac Ca(v)1 channels as a result of phosphorylation by cAMP-dependent protein kinase A. Changes in I(Ca-L) density and kinetics in heart failure often occur in the absence of changes in Ca(v)1 channel expression, arguing for the importance of post-translational modification of these channels in heart disease.

View Article and Find Full Text PDF